SHULMAN JOHN D 4
4 · Petros Pharmaceuticals, Inc. · Filed Nov 30, 2021
Insider Transaction Report
Form 4
SHULMAN JOHN D
Director10% Owner
Transactions
- Purchase
Warrant
2021-11-29+375,000→ 375,000 total(indirect: See Footnote)Exercise: $3.50From: 2021-12-02Exp: 2026-12-02→ Common Stock (375,000 underlying) - Purchase
Common Stock, par value $0.0001 per share
2021-11-29$3.00/sh+500,000$1,500,000→ 5,557,771 total(indirect: See Footnote)
Footnotes (1)
- [F1]See Note (1) in Exhibit 99.1.